Schizophrenia
Conditions
Interventions
None listed
Sponsors
Nippon Boehringer Ingelheim Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [Cohort Physicians] 1.Physicians who are working as psychiatrists in Japan. 2.Physicians who provide informed consent for the survey. 3.Physicians who have routinely treated 10 or more schizophrenia patients in the last three months in clinical practice. 4.Physicians who can enroll at least three schizophrenia patients that subject physicians are in charge of daily treatment into the Cohort Patient survey. [Cohort Patients] 1.Patients who provide informed consent for the survey. 2.Patients who are diagnosed with schizophrenia. 3.Patients who are judged by their physicians to be eligible to participate in the survey (e.g., able to complete the entire online questionnaire using a digital device.) 4.Patients who are over 18 years of age (inclusive) at the time of consent.
Exclusion criteria
Exclusion criteria: [Cohort Physicians] Not applicable [Cohort Patients] 1.Patients who have comorbid conditions with intellectual disability, alcohol / drug abuse, epilepsy, head trauma, and/or cerebrovascular diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| [Cohort Physicians] (1)The psychiatrist's view on the disease management of schizophrenia [Cohort Patients] (1) Patients' recognition of the clinical symptoms of schizophrenia and the motivation for its treatment (2) Patients' burdens and their unmet needs | — |
Countries
Japan
Contacts
Public ContactKaori Inaba
Nippon Boehringer Ingelheim Co., Ltd. Specialty Care Medicine
Outcome results
None listed